Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial

PaperCitations, authors & open-access status

Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 172 citations, 2020 year and green oa status.

172
Citations
2020
Year
green
OA Status

Related on ScholarIQ

Ke Wang
Author
Zhaohui Zheng
Author
medRxiv
Journal
COVID-19 Clinical Research Studies
Topic
COVID-19 Clinical Research Studies
Topic
SARS-CoV-2 and COVID-19 Research
Topic
470M+ articles · free account